Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an ...
An innovative study, co-designed by Aboriginal Women, has led to remission of type 2 diabetes. The research described and ...
West Pharmaceutical Services Inc.'s stock tumbled 33% Thursday, to lead S&P 500 decliners, after the manufacturer of injectable-pharmaceutical packaging and delivery systems offered guidance for 2025 ...
Today, Benzinga's options scanner identified 8 options transactions for DexCom. This is an unusual occurrence. The sentiment ...
Byram Healthcare, part of the Owens & Minor family, has launched ByramConnect, a personalized digital health program for ...
Byram Healthcare, a leader in home-based care and part of the Owens & Minor (NYSE: OMI) family, recently launched ...
Shanghai researchers have devised a revolutionary, non-invasive method to monitor blood glucose, allowing for accurate blood ...
This CGM will track your body's response - Could personalised glucose data inform your body’s metabolism and performance?
Glucotrack has successfully completed its first in-human clinical study for the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein.
Managing diabetes is even harder when temperatures and humidity are rising. Find out how extreme heat can negatively affect ...
The US Food and Drug Administration (FDA) is cautioning patients and caregivers about the potential for not receiving blood ...
U.S. officials are warning about a potentially life-threatening issue with smartphone apps that help manage diabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results